NDC 66215-232

Tracleer

Bosentan

Tracleer is a Oral Tablet, Soluble in the Human Prescription Drug category. It is labeled and distributed by Actelion Pharmaceuticals Us, Inc.. The primary component is Bosentan.

Product ID66215-232_9fd08026-228f-4cd1-aefe-3a2802958bc6
NDC66215-232
Product TypeHuman Prescription Drug
Proprietary NameTracleer
Generic NameBosentan
Dosage FormTablet, Soluble
Route of AdministrationORAL
Marketing Start Date2021-07-29
Marketing CategoryNDA /
Application NumberNDA209279
Labeler NameActelion Pharmaceuticals US, Inc.
Substance NameBOSENTAN
Active Ingredient Strength32 mg/1
Pharm ClassesEndothelin Receptor Antagonist [EPC],Endothelin Receptor Antagonists [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 66215-232-56

4 BLISTER PACK in 1 CARTON (66215-232-56) > 14 TABLET, SOLUBLE in 1 BLISTER PACK (66215-232-14)
Marketing Start Date2021-07-29
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Tracleer" or generic name "Bosentan"

NDCBrand NameGeneric Name
66215-101Tracleerbosentan
66215-102TracleerTracleer
66215-103TracleerTracleer
0054-0520BosentanBosentan
0054-0521BosentanBosentan
0591-2511bosentanbosentan
0591-2512bosentanbosentan
10148-125bosentanbosentan
10148-625bosentanbosentan
46708-383BosentanBosentan
46708-384BosentanBosentan
47335-038BosentanBosentan
47335-039BosentanBosentan
47781-270BosentanBosentan
47781-271BosentanBosentan
49884-058BosentanBosentan
49884-059BosentanBosentan
62332-383BosentanBosentan
62332-384BosentanBosentan
65162-873BosentanBosentan
65162-874BosentanBosentan

Trademark Results [Tracleer]

Mark Image

Registration | Serial
Company
Trademark
Application Date
TRACLEER
TRACLEER
76177722 2648305 Live/Registered
Actelion Pharmaceuticals Ltd.
2000-12-07

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.